Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 18Rhabdomyosarcoma 9Dendritic Cell Sarcoma, Interdigitating 9Osteosarcoma 8Neuroblastoma 8Sarcoma, Ewing 7Burkitt Lymphoma 7Wilms Tumor 6Retinoblastoma 6Medulloblastoma 6Lymphoma 6Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Astrocytoma 5Rhabdoid Tumor 4Recurrence 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Hepatoblastoma 4Central Nervous System Neoplasms 4Carcinoma, Renal Cell 4Brain Neoplasms 4Testicular Neoplasms 3Optic Nerve Glioma 3

Interventions

sargramostim 1indolepropanol phosphate 1Vincristine 1Tirapazamine 1Pharmacogenomic Testing 1Irinotecan 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alveolar Childhood Rhabdomyosarcoma × Granulocyte Colony-Stimulating Factor × Sarcoma × Clear all
NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡